Patents by Inventor Jens-Michael Schroder

Jens-Michael Schroder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cationic intrinsically disordered antimicrobial peptides
    Patent number: 11479587
    Abstract: The present invention generally relates to the field of antimicrobial peptides (AMPs), and more specifically to cationic intrinsically disordered antimicrobial peptides (CIDAMPs) and their use as disinfectants and therapeutic agents for the treatment of infections, especially as a therapeutic alternative for the treatment of infectious diseases caused by antibiotic resistant microorganisms.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: October 25, 2022
    Assignee: Christian-Albrechts-Universität zu Kiel
    Inventor: Jens-Michael Schröder
  • CATIONIC INTRINSICALLY DISORDERED ANTIMICROBIAL PEPTIDES
    Publication number: 20200115426
    Abstract: The present invention generally relates to the field of antimicrobial peptides (AMPs), and more specifically to cationic intrinsically disordered antimicrobial peptides (CIDAMPs) and their use as disinfectants and therapeutic agents for the treatment of infections, especially as a therapeutic alternative for the treatment of infectious diseases caused by antibiotic resistant microorganisms.
    Type: Application
    Filed: November 15, 2017
    Publication date: April 16, 2020
    Applicant: Christian-Albrechts-Universität zu Kiel
    Inventor: Jens-Michael SCHRÖDER
  • Polypeptides and polypeptide analogues
    Publication number: 20060068480
    Abstract: Polypeptides, in particular the polypeptide of formula I: Ala-Gln-Glu-Pro-Val-Lys-Gly-Pro-Val-Ser-Thr-Lys-Pro-Gly-Ser-Cys-Pro-Ile-Ile-Leu-Ile-Arg-Cys-Ala-Met-Leu-Asn-Pro-Pro-Asn-Arg-Cys-Leu-Lys- Asp-Thr-Asp-Cys-Pro-Gly-Ile-Lys-Lys-Cys-Cys-Glu-Gly-Ser-Cys-Gly-Met-Ala-Cys-Phe-Val-Pro-Gln and analogues thereof which possess inhibitory activity against human leukocyte elastase. The polypeptides may be obtained by expression using plasmidic expression systems in hosts such as E. Coli and yeast, the polypeptide of formula I being also obtainable from psoriatic plaques.
    Type: Application
    Filed: March 21, 2005
    Publication date: March 30, 2006
    Applicant: Oliver Wiedow
    Inventors: Enno Christophers, Oliver Wiedow, Jens-Michael Schroder, Michael Edge, David Pioli
  • Nucleic acids
    Patent number: 6893843
    Abstract: Polypeptides, in particular the polypeptide of formula I: Ala-Gln-Glu-Pro-Val-Lys-Gly-Pro-Val-Ser-Thr-Lys- Pro-Gly-Ser-Cys-Pro-Ile-Ile-Leu-Ile-Arg-Cys-Ala- Met-Leu-Asn-Pro-Pro-Asn-Arg-Cys-Leu-Lys-Asp-Thr- Asp-Cys-Pro-Gly-Ile-Lys-Lys-Cys-Cys-Glu-Gly-Ser- Cys-Gly-Met-Ala-Cys-Phe-Val-Pro-Gln and analogues thereof which possess inhibitory activity against human leukocyte elastase. The polypeptides may be obtained by expression using plasmidic expression systems in hosts such as E. Coli and yeast, the polypeptide of formula I being also obtainable from psoriatic plaques.
    Type: Grant
    Filed: April 13, 2001
    Date of Patent: May 17, 2005
    Inventors: Enno Christophers, Oliver Wiedow, Jens-Michael Schroder, Michael Derek Edge, David Pioli
  • Polypeptides and polypeptide analogues
    Publication number: 20020187535
    Abstract: Polypeptides, in particular the polypeptide of formula I: 1 Ala-Gln-Glu-Pro-Val-Lys-Gly-Pro-Val-Ser-Thr-Lys- Pro-Gly-Ser-Cys-Pro-Ile-Ile-Leu-Ile-Arg-Cys-Ala-Met-Leu- Asn-Pro-Pro-Asn-Arg-Cys-Leu-Lys-Asp-Thr-Asp-Cys-Pro-Gly- Ile-Lys-Lys-Cys-Cys-Glu-Gly-Ser-Cys-Gly-Met-Ala-Cys- Phe-Val-Pro-Gln
    Type: Application
    Filed: April 13, 2001
    Publication date: December 12, 2002
    Inventors: Enno Christophers, Oliver Wiedow, Jens-Michael Schroder, Michael Derek Edge, David Pioli
  • polypeptides and polypeptide analogues
    Patent number: 6245739
    Abstract: Polypeptides, in particular the polypeptide of formula I: Ala-Gln-Glu-Pro-Val-Lys-Gly-Pto-Val-Ser-Thr-Lys-Pro-Gly-Ser-Cys-Pro-Ile-Ile-Leu-Ile-Arg-Cys-Ala-Het-Leu-Asn-Pro-Pro-Asn-Arg-Cys-Leu-Lys-Asp-Thr-Asp-Cys-Pro-Gly-Ile-Lys-Lys-Cys-Cys-Glu-Gly-Ser-Cys-Gly-Met-Ala-Cys-Phe-Val-Pro-Gln and analogues thereof which possess inhibitory activity against human leukocyte elastase. The polypeptides may be obtained by expression using plasmidic expression systems in hosts such as E. Coli and yeast, the polypeptide of formula I being also obtainable from psoriatic plaques.
    Type: Grant
    Filed: April 24, 1995
    Date of Patent: June 12, 2001
    Inventors: Enno Christophers, Oliver Wiedow, Jens-Michael Schroder
  • Polypeptides and polypeptide analogues
    Patent number: 5464822
    Abstract: Polypeptides, in particular the polypeptide of formula I: ##STR1## and analogues thereof which possess inhibitory activity against human leukocyte elastase. The polypeptides may be obtained by expression using plasmidic expression systems in hosts such as E. Coli and yeast, the polypeptide of formula I being also obtainable from psoriatic plaques.
    Type: Grant
    Filed: August 10, 1992
    Date of Patent: November 7, 1995
    Assignee: Zeneca Limited
    Inventors: Enno Christophers, Oliver Wiedow, Jens-Michael Schroder
  • Substance with interleukin-8 inhibiting activity and process for its preparation
    Patent number: 5234911
    Abstract: A substance is prepared having interleukin-8 inhibiting activity by extracting psoriatic scales and separating the extract on several successive HPLC columns, using an assay for IL-8i activity based on the inhibition of myeloperoxidase release and/or of the neutrophil chemotaxis of a reference sample.The substance is suitable for the preparation of anti-inflammatory medicines.
    Type: Grant
    Filed: January 16, 1991
    Date of Patent: August 10, 1993
    Assignee: Gist-brocades, N.V.
    Inventors: Enno Christophers, Jens-Michael Schroder